热评:体检乱象频现,产业链应补上这关键一环

2018-12-06 乔宁 健康报医生频道

近日,国内某知名体检公司老总在公开场合自曝行业乱象,称一些同行用护士假冒医生做超声检查,血检样本直接扔掉出具假结果。虽无“实锤”抛出,但依然引发社会广泛关注。


近日,国内某知名体检公司老总在公开场合自曝行业乱象,称一些同行用护士假冒医生做超声检查,血检样本直接扔掉出具假结果。虽无“实锤”抛出,但依然引发社会广泛关注。

伴随居民经济生活水平的提升、企业福利制度的完善和预防为主理念的深入,体检越来越被人们所重视。相关各方在健康体检方面投入大量资金和资源,希望可以借此实现疾病的早发现、早诊断、早治疗,进而降低个人、用人单位乃至整个社会的疾病负担。然而如今,体检机构频曝丑闻,公众气愤之余疑虑丛生。体检行业究竟状况如何?是否沦落到不可信任的不堪地步?针对这些问题,监管部门、行业协会宜尽快组织业内调查,以真实数据给公众一个明白交代。遮遮掩掩、避而不答或运动式整改,只会降低行业整体信誉度,折损企业经济收益和人群健康收益。

体检行业近年来风评下降,还在于不少体检者自感投入和收益不成正比。一方面,个人和用人单位追求价廉物美甚至物超所值,但基于经济成本设计的常规体检项目,难以实现个性化、精准化检测;另一方面,体检机构追求效益最大化,炒作推广诸如基因检测等新兴概念产品,体检者在高价埋单之后往往只得到不具明确意义的检查结果。要想在健康收益和经济投入之间找到最佳平衡点,体检者和用人单位既要以足够的健康素养加身,借此避免信息不对称造成的选择失误,又要掂量掂量自己的荷包,在追求体检方案个性化、精准化的同时,尽量减少低产出花费。而体检机构也应意识到,适应消费者需求,设计出品类更丰富、个性化、可负担的产品线,将是谋求良性发展的必然选择。

体检行业乱象的再次爆出,也给各方提供了一个思考的机会。问题早已有之,呼吁加强监管之声不绝于耳,为何收效甚微?对于规范促进产业健康发展,政府监管职责自不待言,但倘若将一切希望寄托于加强监管,既有违客观现实,为此付出的行政成本也恐令各方难以承受。市场经济体制运行多年,我们在追求建立“有效政府”的同时,也应努力打造“有效市场”。具体到体检行业中,保险公司的加入或许能为摆脱当下困境找到新办法。作为给付方,其既有经济动力又有专业背景,有望最大程度地保证体检方案物有所值,监督体检机构规范执业。串起给付方、实施方、监督方的完整利益链条,形成各方环环相扣、互相监督的运行机制,体检市场有机会实现多方共赢。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1755272, encodeId=3dbb1e552721f, content=<a href='/topic/show?id=14e123562d0' target=_blank style='color:#2F92EE;'>#乱象#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23562, encryptionId=14e123562d0, topicName=乱象)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=842136851119, createdName=zhangjingnwpu, createdTime=Sun Jan 13 16:12:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305155, encodeId=77d9130515546, content=<a href='/topic/show?id=ba392659e58' target=_blank style='color:#2F92EE;'>#体检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26597, encryptionId=ba392659e58, topicName=体检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Sat Dec 08 08:12:00 CST 2018, time=2018-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1572931, encodeId=91c615e2931b5, content=<a href='/topic/show?id=7e5a24416c3' target=_blank style='color:#2F92EE;'>#产业链#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24416, encryptionId=7e5a24416c3, topicName=产业链)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71bd15785338, createdName=apoenzyme, createdTime=Sat Dec 08 08:12:00 CST 2018, time=2018-12-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1755272, encodeId=3dbb1e552721f, content=<a href='/topic/show?id=14e123562d0' target=_blank style='color:#2F92EE;'>#乱象#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23562, encryptionId=14e123562d0, topicName=乱象)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=842136851119, createdName=zhangjingnwpu, createdTime=Sun Jan 13 16:12:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305155, encodeId=77d9130515546, content=<a href='/topic/show?id=ba392659e58' target=_blank style='color:#2F92EE;'>#体检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26597, encryptionId=ba392659e58, topicName=体检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Sat Dec 08 08:12:00 CST 2018, time=2018-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1572931, encodeId=91c615e2931b5, content=<a href='/topic/show?id=7e5a24416c3' target=_blank style='color:#2F92EE;'>#产业链#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24416, encryptionId=7e5a24416c3, topicName=产业链)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71bd15785338, createdName=apoenzyme, createdTime=Sat Dec 08 08:12:00 CST 2018, time=2018-12-08, status=1, ipAttribution=)]
    2018-12-08 marongnuan
  3. [GetPortalCommentsPageByObjectIdResponse(id=1755272, encodeId=3dbb1e552721f, content=<a href='/topic/show?id=14e123562d0' target=_blank style='color:#2F92EE;'>#乱象#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23562, encryptionId=14e123562d0, topicName=乱象)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=842136851119, createdName=zhangjingnwpu, createdTime=Sun Jan 13 16:12:00 CST 2019, time=2019-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305155, encodeId=77d9130515546, content=<a href='/topic/show?id=ba392659e58' target=_blank style='color:#2F92EE;'>#体检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26597, encryptionId=ba392659e58, topicName=体检)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Sat Dec 08 08:12:00 CST 2018, time=2018-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1572931, encodeId=91c615e2931b5, content=<a href='/topic/show?id=7e5a24416c3' target=_blank style='color:#2F92EE;'>#产业链#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24416, encryptionId=7e5a24416c3, topicName=产业链)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71bd15785338, createdName=apoenzyme, createdTime=Sat Dec 08 08:12:00 CST 2018, time=2018-12-08, status=1, ipAttribution=)]